Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Steven R. DeGoey"'
Autor:
Manish J. Gandhi, Laurie L. Wakefield, Byron H. Smith, Donald Mitema, Carrie A. Schinstock, M. Moreno Gonzales, Nicole Henderson, Mark D. Stegall, Steven R. DeGoey, Justin D. Kreuter
Publikováno v:
Transplantation Proceedings. 49:2031-2035
Complement-binding donor-specific antibodies (DSAs) are associated with antibody-mediated rejection and allograft loss. Novel single antigen bead (SAB) assays-that is, complement component 1q (C1q) and complement component 3d (C3d) assays-have been d
Autor:
James M. Gloor, Sanjeev Sethi, Fernando G. Cosio, Walter D. Park, Matthew D. Griffin, S. B. Moore, Mark D. Stegall, Steven R. DeGoey, Timothy S. Larson
Publikováno v:
American Journal of Transplantation. 7:2124-2132
Transplant glomerulopathy (TG) usually has been described as part of a constellation of late chronic histologic abnormalities associated with proteinuria and declining function. The current study used both protocol and clinically-indicated biopsies t
Autor:
James M. Gloor, Joseph P. Grande, David J. Rea, Fernando G. Cosio, Hani M. Wadei, Donna J. Lager, Mark D. Stegall, S. B. Moore, Jeffrey L. Winters, Steven R. DeGoey
Publikováno v:
American Journal of Transplantation. 6:1841-1847
Recent protocols have allowed successful positive crossmatch (+XM) and ABO incompatible (ABOI) kidney transplantation, although their long-term outcome is not clear. To begin to assess this issue we compared protocol biopsies performed 12 months post
Autor:
James M. Gloor, Steven R. DeGoey, Mark D. Stegall, Howard Gebel, S. Breanndan Moore, Nancy A. Ploeger, Robert A. Bray, Patrick G. Dean
Publikováno v:
Transplantation. 78:221-227
BACKGROUND : Desensitization protocols have been developed to allow successful kidney transplantation in sensitized recipients. However, a detailed analysis of the impact of these protocols on alloantibody has not been performed. METHODS : We studied
Publikováno v:
Transplantation. 64:1617-1620
Background. IgG antibodies to HLA class I antigens can cause hyperacute rejection of renal allografts. Screening of sera from such transplant candidates is laborious, time-consuming, and expensive when performed by sensitive antihuman globulin-augmen
Autor:
David F. Lorentzen, Steven R. DeGoey, Manish J. Gandhi, Mark D. Stegall, Sarah M. Jenkins, Deborah K. Falbo, James R. Stubbs, Jar How Lee, Harriet Noreen
Publikováno v:
Human immunology. 74(3)
Single antigen bead based assays (SAB) to identify antibodies to HLA are marketed as a qualitative test, however often used as a quantitative test as the results provide mean fluorescence intensity (MFI) which is found to correlate with the strength/
Autor:
Manish J. Gandhi, Lynette Fix, R. Knauer, Lynn D. Cornell, Walter K. Kremers, Steven R. DeGoey, Jeffrey L. Winters, Fernando G. Cosio, James M. Gloor, Mark D. Stegall
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 10(3)
Renal transplant candidates with donor-specific alloantibody (DSA) have increased risk of antibody-mediated allograft injury. The goal of this study was to correlate the risk of antibody-mediated rejection (AMR), transplant glomerulopathy (TG) and gr
Publikováno v:
Transplantation. 84(2)
Background. We evaluated the effect of antithymocyte globulin (ATG) on anti-human leukocyte antigen (HLA) antibody assays. Methods. We tested sera from six in vivo ATG-treated kidney transplant patients after measuring serum concentrations, as well a
Autor:
Rimki Rana, Rolf D. Hubmayr, S. Breanndan Moore, Laura K. Evenson, Steven R. DeGoey, Megan M. O’Byrne, Michael Malinchoc, Ognjen Gajic, Jose L. Mendez, Bekele Afessa, Jeffrey L. Winters, Otis B. Rickman, Murat Yilmaz
Acute lung injury (ALI) that develops 6 hours after transfusion (TRALI) is the leading cause of transfusion-related mortality. Several transfusion characteristics have been postulated as risk factors for TRALI, but the evidence is limited to retrospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20db97ee5f9eb50c1847818267777559
https://europepmc.org/articles/PMC2048675/
https://europepmc.org/articles/PMC2048675/
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 6(2)
Several protocols allow for the successful transplantation of sensitized renal allograft recipients, yet no one best method has emerged. The aim of the current study was to compare the efficacy of high-dose IVIG with two different plasmapheresis (PP)